Locations:
Search
Phase 1 study found mutant calreticulin-specific monoclonal antibody brings promising results with no dose-limiting toxicities
Cleveland Clinic psychiatrist urges integrating psychosocial care into oncology
A retrospective analysis
Simple score uses clinical factors to identify patients who might benefit from earlier screening
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Noninvasive treatment may slow progression of Dupuytren's disease and plantar fibromatrosis
Age alone should not rule out patients from potentially curative treatment
Oncologic and functional outcomes are promising, but selection is key
Reconsidering axillary lymph node dissection as well as depth of surgical margins
Pediatric specialists unpack new evidence, considerations for care and what’s ahead
Researchers uncover profound differences in the mechanism of action between different PD-L1 checkpoint inhibitors
Advertisement
Advertisement